NASDAQ · Biotechnology

ALEC (ALEC) Stock

$1.52 +0.33% NASDAQ: ALEC Healthcare

Valuation

MetricValue
Price$1.52
Market Cap$168.20M
P/E Ratio-1.58
P/B Ratio7.83
P/S Ratio12.78
EPS (TTM)$-1.39
52-Week High$3.40
52-Week Low$1.09
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-461.29%
ROA-48.81%
ROCE-486.67%
Gross Margin-695.24%
Operating Margin-695.24%
Net Margin-6.81%
Debt/Equity3.33
Current Ratio3.80

Annual Financials (USD)

Metric20212022202320242025
Revenue$207.0M$134.0M$97.0M$101.0M$21.0M
Operating Profit$-37.0M$-138.0M$-152.0M$-145.0M$-146.0M
Net Profit$-36.0M$-133.0M$-130.0M$-119.0M$-143.0M
EPS$-0.45$-1.62$-1.56$-1.23$-1.39
Op Margin-18.0%-103.2%-156.3%-144.2%-692.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$815.0M$788.0M$622.0M$468.0M$293.0M
Total Liabilities$514.0M$573.0M$488.0M$342.0M$263.0M
Cash$329.0M$154.0M$75.0M$33.0M$66.0M
Borrowings$48.0M$43.0M$39.0M$43.0M$36.0M

Latest News

GSK ends brain drug alliance with Alector BioPharma Dive · Jul 9, 2026 Alector (ALEC) Stock Faces Mixed Analyst Target Changes On Tau Therapy Readthrough Simply Wall St. · Jun 19, 2026 How The Alector (ALEC) Investment Story Is Shifting With Tau Readthroughs And BBB Shuttle Focus Simply Wall St. · May 19, 2026 Alector (ALEC) Reports Q1 Loss, Lags Revenue Estimates Zacks · May 7, 2026 Alector: Q1 Earnings Snapshot Associated Press · May 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$299.0M$-20.0M$-184.0M$-230.0M$-184.0M
Investing Cash Flow$-53.0M$-163.0M$100.0M$106.0M$197.0M
Financing Cash Flow$30.0M$0$0$1.0M$0
Net Cash Flow$279.0M$-175.0M$-80.0M$-41.0M$33.0M
Free Cash Flow$295.0M$-24.0M$-187.0M$-231.0M$-184.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-73.59%
Quick Ratio5.25
Interest Coverage—
Return 1Y-16.77%
Return 3Y-78.55%
Return 5Y-95.84%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABOS $2.27 -0.66% -1.17 $163.60M 0.00%
APLTApplied Therapeutics, Inc. $0.10 +0.00% -0.24 $14.86M 0.00%
CRBP $9.11 +0.33% -1.95 $168.79M 0.00%
FATE $2.31 -0.43% -1.62 $269.25M 0.00%
IRDOpus Genetics, Inc. $3.32 +7.63% -2.35 $273.71M 0.00%

About ALEC

ALEC is led by CEO Arnon Rosenthal, publicly traded since 2019.

ALEC stock trades at $1.52 with a market capitalization of $168.20M. The stock is valued at a price-to-earnings (P/E) ratio of -1.58, price-to-book of 7.83, price-to-sales of 12.78. Over the past 52 weeks the stock has ranged between $1.09 and $3.40, and currently trades 55.3% below its 52-week high.

On profitability, ALEC generates a return on equity (ROE) of -461.29%, return on capital employed of -486.67%, an operating margin of -695.24%, a net profit margin of -6.81%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides